Novavax, Inc.
NVAX
$9.06
-$0.29-3.10%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -101.83% | 121.63% | -66.84% | -34.41% | 451.51% |
| Total Depreciation and Amortization | -63.29% | -59.06% | -48.15% | -32.06% | -31.34% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -103.62% | 120.67% | 752.29% | -104.71% | 54.19% |
| Change in Net Operating Assets | 96.62% | -51.51% | 416.85% | -308.57% | -2,258.47% |
| Cash from Operations | 82.52% | 77.20% | 174.44% | -140.56% | -122.01% |
| Capital Expenditure | 20.38% | -7.45% | -47.01% | 91.41% | 76.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 62.23% | 148.30% | -504.13% | 130.11% | -19,180.65% |
| Cash from Investing | 61.32% | -85.78% | -527.83% | 129.81% | -911.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 73.74% | -127.65% | -92.19% | -67.21% | -511.39% |
| Issuance of Common Stock | -- | -- | 1,174.22% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -67.86% | -- | -- | 688.96% | -688.96% |
| Cash from Financing | 633.56% | -92.99% | 43,854.64% | -100.40% | -219.96% |
| Foreign Exchange rate Adjustments | 98.06% | 84.05% | -89.08% | 5,167.95% | 68.53% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 91.33% | 36.93% | 113.44% | -104.76% | -203.63% |